Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea

J Clin Gastroenterol. 2007 Nov-Dec;41(10):932-3. doi: 10.1097/01.mcg.0000225685.37465.e7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Clostridioides difficile / drug effects*
  • Diarrhea / drug therapy*
  • Diarrhea / microbiology
  • Diarrhea / prevention & control
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Enterocolitis, Pseudomembranous / drug therapy*
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / prevention & control
  • Humans
  • Male
  • Middle Aged
  • Rifamycins / administration & dosage
  • Rifamycins / therapeutic use*
  • Rifaximin
  • Secondary Prevention
  • Treatment Outcome
  • Vancomycin / administration & dosage
  • Vancomycin / therapeutic use*

Substances

  • Anti-Infective Agents
  • Rifamycins
  • Vancomycin
  • Rifaximin